Page last updated: 2024-09-03

tyrosyl-arginyl-phenylalanyl-sarcosine and ethylketocyclazocine

tyrosyl-arginyl-phenylalanyl-sarcosine has been researched along with ethylketocyclazocine in 1 studies

Compound Research Comparison

Studies
(tyrosyl-arginyl-phenylalanyl-sarcosine)
Trials
(tyrosyl-arginyl-phenylalanyl-sarcosine)
Recent Studies (post-2010)
(tyrosyl-arginyl-phenylalanyl-sarcosine)
Studies
(ethylketocyclazocine)
Trials
(ethylketocyclazocine)
Recent Studies (post-2010) (ethylketocyclazocine)
150155933

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheong, YP; Cho, KP; Kim, CJ; Kim, JK; Kim, KW; Kwun, J; Woo, RS1

Other Studies

1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-sarcosine and ethylketocyclazocine

ArticleYear
Receptor selectivity of Met-enkephalin-Arg6-Phe7, an endogenous opioid peptide, in cerebral cortex of human and rat.
    Life sciences, 2000, May-26, Volume: 67, Issue:1

    Topics: Adult; Animals; Benzeneacetamides; Benzomorphans; Binding Sites; Cerebral Cortex; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Methionine; Ethylketocyclazocine; Female; Humans; Male; Naloxone; Naltrexone; Norepinephrine; Oligopeptides; Peptide Fragments; Peptides; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Somatostatin

2000